why choose us

First received: May 18, 2023

Clinical Trial: BALANCE+ Vanguard Phase

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gram-negative Bacteremia

Study Type: INTERVENTIONAL


Official Title: BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

Brief Summary: The goal of the BALANCE+ clinical trial is to transform random care to randomized care for patients with Gram negative bloodstream infections to inform best treatment approaches and optimize outcomes.BALANCE+, a perpetual platform trial, will efficiently answer multiple questions that are important for hospitalized patients with Gram negative bloodstream infections.

Read more